NCT03500991: HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors |
|
|
| Active, not recruiting | 1 | 10 | US | HER2-specific chimeric antigen receptor (CAR) T cell | Seattle Children's Hospital | Central Nervous System Tumor, Pediatric, Glioma, Ependymoma, Medulloblastoma, Germ Cell Tumor, Atypical Teratoid/Rhabdoid Tumor, Primitive Neuroectodermal Tumor, Choroid Plexus Carcinoma, Pineoblastoma | 07/24 | 07/39 | | |
